FindTrial
Sign In

Effectiveness of Homoeopathic Treatment in Children with Atopic Dermatitis (Eczema).

A Prospective, Single-Arm Study on the Effectiveness of Homoeopathic Treatment in the Management of Atopic Dermatitis in the Paediatric Age Group Using SCORAD and CDLQI Scales - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112222
Enrollment
30
Registered
2026-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Patients will receive individualized homoeopathic treatment in dosage of 3-5 globules per day, frequency of 3 days in a duration of 12 months. Cont

Sponsors

JSPS Government Homoeopathic Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 1 to 18 years, of either sex. Diagnosed with Atopic Dermatitis using Hanifin and Rajka diagnostic criteria (1980). Willing to receive only individualized Homoeopathic treatment throughout the study.

Exclusion criteria

Exclusion criteria: Children with any systemic or complicated medical condition (e.g., uncontrolled asthma, diabetes, congenital heart disease, immunodeficiencies, etc.). Unwillingness to participate or poor compliance with the treatment protocol (e.g., missed follow- ups, irregular medication usage).

Design outcomes

Primary

MeasureTime frame
Change in severity of Atopic Dermatitis as assessed by SCORAD (Scoring Atopic Dermatitis) Index and improvement in quality of life as assessed by CDLQI (Children s Dermatology Life Quality Index) following individualized Homoeopathic treatmentTimepoint: Baseline, 9 months, and 18 months after initiation of treatment.—

Secondary

MeasureTime frame
Assessment of progression toward other atopic conditions (Atopic March), such as allergic rhinitis and asthma, during the study period.Timepoint: Baseline and 18 months.—

Countries

India

Contacts

Public ContactDr C Nanda Kishori

JSPS Govt Homoeopathic medical college

drnandakishori@gmail.com9515225291

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026